Company
Octave Bioscience
| Industry | commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (SVB) a Division of First Citizens Bank |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Octave Bioscience | Series C | 2025-09-05 |
| Octave Bioscience | Series B Extension | 2023-07-26 |